“Thank You for Keeping Me and My Baby Safe”: Emily’s Story with Dart-Care

Emily* had been managing her psoriasis with Stelara® for several years. She started the medication before getting married, and for a long time, it helped her feel confident, healthy, and in control.

When Emily and her husband decided it was time to grow their family, she continued her usual routine—until a routine check-in through the Dart-Care program made all the difference.

During her annual medication therapy management (MTM) session, the CSP pharmacist reviewing Emily’s profile requested updated lab work. As part of the standard process, Dart-Care followed up with her physician—and learned something critical: Emily was pregnant.

This discovery immediately triggered a clinical safety review. Stelara is not recommended during pregnancy due to potential risks to both mother and baby. Because of Dart-Care’s proactive monitoring and coordination with her care team, the medication was stopped right away—closing a serious gap in care.

When Emily learned what had happened behind the scenes, she was deeply moved. “Thank you for keeping me and my baby safe,” she told us.

 For Dart-Care, safety isn’t just a protocol—it’s a promise. We are proud to walk alongside patients like Emily, making sure no one falls through the cracks.

*Name changed for privacy.